OCT-Angiography for Age-Related Macular Degeneration
What OCT-A Shows in AMD
OCT-A creates detailed maps of blood flow inside your eye by detecting the movement of red blood cells through retinal vessels. This technology can reveal changes that are not visible through standard eye exams, making it a valuable part of AMD imaging.
The technology works by taking multiple rapid scans of the same area of the retina and comparing them to detect movement. Because only moving blood cells produce a signal, the result is a precise map showing where blood is actively flowing and where it is not. This all happens without any dye injected into a vein.
The scans are depth-resolved, meaning your doctor can view blood flow at different layers of the retina separately, from the surface vessels down to the deeper choroidal (below the retina) circulation where AMD changes often begin.
In wet AMD, abnormal blood vessels grow beneath the retina in a process called macular neovascularization (MNV). OCT-A is highly sensitive at detecting these vessels and can show both their structure and whether blood is actively flowing through them.
This matters because active vessels with visible flow indicate ongoing disease that typically requires treatment, while inactive vessels without flow may suggest the neovascularization has been controlled. Your doctor uses this distinction to decide how to adjust your care plan.
Geographic atrophy (GA) is the advanced form of dry AMD in which retinal cells gradually die, causing permanent blind spots. OCT-A can detect loss of blood flow in the choriocapillaris, the small vessel layer just beneath the retina, before the retinal cells above it have died.
This early flow loss can signal where GA is likely to expand next, giving your doctor a way to track progression and assess how well treatments designed to slow GA are working.
How OCT-A Fits Into Your AMD Care
OCT-A is not a standalone test. It is most useful when considered alongside your symptoms, examination findings, and results from other imaging tools. Your doctor uses it at key moments throughout your care to build a more complete picture of what is happening in your macula.
A specialist may order OCT-A during your initial AMD evaluation, at routine monitoring visits, or when standard OCT results raise questions that need further investigation. Because no dye injection is involved, OCT-A can be repeated as often as your condition requires without the risks associated with dye-based testing.
Standard OCT and OCT-A are often performed during the same appointment. Each test provides different information, and together they give your doctor a fuller view of your macula.
- Standard OCT shows retinal structure, fluid buildup, and tissue thickness
- OCT-A maps blood vessel patterns and flow at each retinal depth
- Together, they reveal both structural changes and vascular activity in one visit
This combination allows your doctor to understand not just whether fluid is present, but also what is driving it and how the blood vessels are behaving.
Anti-VEGF injections are the standard treatment for wet AMD. They work by blocking a protein called vascular endothelial growth factor (VEGF) that stimulates abnormal vessel growth. OCT-A helps your doctor evaluate whether those vessels are still active, which informs decisions about continuing treatment, extending time between injections, or adjusting your care plan.
Reactivation of previously quiet vessels is possible, so your doctor continues to monitor with OCT-A even when vessels appear inactive.
Limitations of OCT-Angiography
OCT-A is a highly capable tool, but it does have limitations that your doctor accounts for when planning your imaging. Understanding these limitations helps explain why other tests are sometimes needed alongside OCT-A.
OCT-A captures a smaller portion of the retina compared to dye-based angiography. If abnormal vessels lie outside the scanned area, they may not appear in the results. Your doctor focuses the scan on the macula, where AMD changes occur most often, but may need additional scans or a different test to evaluate the areas beyond that zone.
Eye movement during the scan can create artifacts, which are visual distortions that reduce image quality and make results harder to interpret. Patients who have difficulty holding a steady gaze may produce less reliable images. Dense cataracts or other conditions that cloud the eye's optical media can also interfere with the OCT-A signal, sometimes preventing usable results.
When image quality is consistently poor, your doctor may recommend a different imaging approach.
OCT-A shows blood vessel structure and flow, but it cannot capture dye leakage the way fluorescein angiography (FA) can. FA uses injected dye to show the timing and pattern of leakage from abnormal vessels, which some specialists use to classify vessel subtypes and assess leakage activity.
When that specific information is needed, FA remains the more appropriate tool. For most routine monitoring of known wet AMD, OCT-A typically provides sufficient information without requiring dye.
What to Expect During an OCT-A Scan
OCT-A is a quick, comfortable procedure that most patients find straightforward. Knowing what to expect can help reduce any anxiety and ensure you are prepared for your appointment.
No dye injection, intravenous line, or special preparation is required before an OCT-A scan. You will sit at the imaging machine, rest your chin on a support, and look at a target light while the device takes images. Each eye typically takes just a few minutes to scan.
Your doctor may or may not dilate your pupils depending on the imaging protocol used at your visit. If dilation is needed, you should plan for some temporary light sensitivity and blurred near vision afterward.
Images are processed and available for review immediately after the scan. Your doctor will go over the vascular maps with you during the same visit, explaining what the results show and how they relate to your AMD. All images are saved to your medical record so they can be compared to future scans to track changes over time.
Most people with AMD can undergo OCT-A safely. Patients who cannot tolerate fluorescein dye due to allergies or other concerns benefit particularly from this dye-free option. However, patients with dense cataracts or significant cloudiness in the eye may not produce images clear enough to be useful.
Your doctor will determine whether OCT-A can provide the information needed for your specific situation or whether a different test would be more appropriate.
Frequently Asked Questions
These answers address common questions patients have about OCT-A that go beyond the basics covered above.
For many routine AMD monitoring situations, OCT-A has become the preferred first-line imaging tool because it is dye-free and fast. However, fluorescein angiography (FA) still provides unique information about dye leakage timing and certain vessel classifications that OCT-A cannot replicate. Your doctor will use FA when that specific level of detail is necessary and rely on OCT-A for regular follow-up monitoring in most cases.
Yes. OCT-A can identify abnormal blood vessel growth and blood flow changes before vision symptoms become noticeable. This is one of the most important advantages of the technology, because starting anti-VEGF treatment early, before leakage causes significant damage to central vision, generally leads to better long-term outcomes than waiting until symptoms appear. Regular monitoring makes this early detection possible.
The schedule depends on your AMD type, how stable your condition is, and whether you are actively receiving anti-VEGF injections. Patients on active treatment may have OCT-A imaging at each visit or at selected intervals between injections. Patients with stable dry AMD may be monitored less frequently. Your doctor will set a schedule based on your individual needs and adjust it as your condition changes.
Many insurance plans, including Medicare, cover OCT-A when it is ordered for AMD diagnosis or monitoring. Coverage can vary depending on your specific plan and the clinical reason for the test. It is worth confirming your benefits before your appointment so there are no surprises regarding out-of-pocket costs.
Poor image quality can occur due to eye movement, cataracts, or other conditions affecting the clarity of the eye's optical media. If your images are not clear enough to be useful, your doctor may try repositioning the scan, request a follow-up imaging session, or recommend an alternative test such as fluorescein angiography to get the information needed. Your doctor will always choose the approach that gives the most reliable result for your situation.
See an AMD Specialist for Expert Imaging and Care
Managing AMD requires precise, ongoing monitoring, and OCT-A is one of the most important tools available for doing that well. Our specialists use advanced imaging to guide every stage of your care, from early detection through long-term treatment management. We welcome you to schedule a visit and experience the level of attention and expertise your vision deserves.
ClÃnica fantástica. El Dr. Fernández resuelve rápidamente los problemas que ve en el momento y recomienda soluciones para seguir adelante. Siempre hay disponibilidad para emergencias, etc.
Shyam Srinivasan
Recibimiento cálido. Pruebas de preparación cuidadosas. Examen profesional con el Dr. Fernandes, quien me explicó lo que estaba haciendo en cada paso del proceso.
karen cook
Siempre es un placer ver al Dr. Fernandes. El doctor y el personal son muy profesionales, amables y comprensivos.
Christina
Great front desk staff! The office is immaculate! The ophthalmology exam was thorough and precise. Highly recommend this place.
Wajeeha Faizi
El Dr. Fernandes ha sido completamente honesto y muy servicial conmigo desde el principio. La recepcionista y todo el personal de apoyo son muy amables y siempre hacen que el paciente se sienta cómodo.
bruce hulman